نتائج البحث - Muhammad Waqas Sadiq

  • يعرض 1 - 5 نتائج من 5
تنقيح النتائج
  1. 1
    Diphenhydramine Active Uptake at the Blood–Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo

    Diphenhydramine Active Uptake at the Blood–Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo حسب Muhammad Waqas Sadiq, Annika Borgs, Takashi Okura, Keita Shimomura, Sayaka Kato, Yoshiharu Deguchi, Britt Jansson, Sven Björkman, Tetsuya Terasaki, Margareta Hammarlund‐Udenaes

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection

    A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection حسب Muhammad Waqas Sadiq, Elisabet I. Nielsen, Dalia Khachman, Jean‐Marie Conil, Bernard Georges, Georges Houin, Céline M. Laffont, Mats O. Karlsson, Lena E. Friberg

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease

    Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease حسب Muhammad Waqas Sadiq, Hongtao Yu, Magnus Åstrand, Ian C. Scott, Adam Williams, Lisa Hewitt, N. E. White, Helen Killick, Monica L. Gavala, E. Suzanne Cohen, Fred Reid, Chris Kell, Hitesh Pandya, Eulalia Jiménez

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4

    A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4 حسب Dave Singh, Patricia Guller, Fred Reid, Sarah Doffman, Ulla Seppälä, Ioannis Psallidas, Rachel Moate, Rebecca Smith, Joanna Kiraga, Eulalia Jiménez, Dennis E. Brooks, Aoife Kelly, Lars H. Nordenmark, Muhammad Waqas Sadiq, Luis Mateos Caballero, Chris Kell, Maria G. Belvisi, Hitesh Pandya

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease

    A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease حسب Fred Reid, Dave Singh, Muna Albayaty, Rachel Moate, Eulalia Jiménez, Muhammad Waqas Sadiq, David Howe, Monica L. Gavala, Helen Killick, Adam Williams, Surekha Krishnan, A. Godwood, Animesh Shukla, Lisa Hewitt, Alejhandra Lei, Chris Kell, Hitesh Pandya, Paul J. Newcombe, N. E. White, Ian C. Scott, E. Suzanne Cohen

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: